RAGE enhances TLR responses through binding and internalization of RNA

Journal of Immunology

Volumn 197, Issue 10, 2016, Pages 4118-4126

  Bertheloot, Damien ^a   Naumovski, Allison L ^b   Langhoff, Pia ^a,c   Horvath, Gabor L ^a   Jin, Tengchuan ^d   Xiao, Tsan Sam ^e   Garbi, Natalio ^f   Agrawal, Sudhir ^g   Kolbeck, Roland ^b   Latz, Eicke ^a,b,h  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b MEDIMMUNE   (United States)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BONN   (Germany)

^g HYBRIDON INC   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 13; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; DNA; RNA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL SURFACE; CONTROLLED STUDY; EMBRYO; ENDOSOME; FEMALE; GENE LOCATION; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; DNA; ENDOSOMES; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; TOLL-LIKE RECEPTORS;

EID: 84994406990     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502169     Document Type: Article

References (58)

1. Barton, G. M., and J. C. Kagan. 2009. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 9: 535-542.
2. Blasius, A. L., and B. Beutler. 2010. Intracellular toll-like receptors. Immunity 32: 305-315.
3. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
4. Ohto, U., T. Shibata, H. Tanji, H. Ishida, E. Krayukhina, S. Uchiyama, K. Miyake, and T. Shimizu. 2015. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature 520: 702-705.
5. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
6. Hidmark, A., A. von Saint Paul, and A. H. Dalpke. 2012. Cutting edge: TLR13 is a receptor for bacterial RNA. J. Immunol. 189: 2717-2721.
7. Oldenburg, M., A. Krüger, R. Ferstl, A. Kaufmann, G. Nees, A. Sigmund, B. Bathke, H. Lauterbach, M. Suter, S. Dreher, et al. 2012. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337: 1111-1115.
8. Tanji, H., U. Ohto, T. Shibata, M. Taoka, Y. Yamauchi, T. Isobe, K. Miyake, and T. Shimizu. 2015. Toll-like receptor 8 senses degradation products of singlestranded RNA. Nat. Struct. Mol. Biol. 22: 109-115.
9. Kanno, A., N. Tanimura, M. Ishizaki, K. Ohko, Y. Motoi, M. Onji, R. Fukui, T. Shimozato, K. Yamamoto, T. Shibata, et al. 2015. Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases. Nat. Commun. 6: 6119.
10. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
11. Brinkmann, M. M., E. Spooner, K. Hoebe, B. Beutler, H. L. Ploegh, and Y.-M. Kim. 2007. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 177: 265-275.
12. Kim, Y.-M., M. M. Brinkmann, M.-E. Paquet, and H. L. Ploegh. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452: 234-238.
13. Itoh, H., M. Tatematsu, A. Watanabe, K. Iwano, K. Funami, T. Seya, and M. Matsumoto. 2011. UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS One 6: e28500.
14. Yasutomo, K., T. Horiuchi, S. Kagami, H. Tsukamoto, C. Hashimura, M. Urushihara, and Y. Kuroda. 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat. Genet. 28: 313-314.
15. Napirei, M., H. Karsunky, B. Zevnik, H. Stephan, H. G. Mannherz, and T. Möröy. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25: 177-181.
16. Stetson, D. B., J. S. Ko, T. Heidmann, and R. Medzhitov. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134: 587-598.
17. Brencicova, E., and S. S. Diebold. 2013. Nucleic acids and endosomal pattern recognition: how to tell friend from foe? Front. Cell. Infect. Microbiol. 3: 37.
18. Means, T. K., E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
19. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
20. Lahoud, M. H., F. Ahmet, J.-G. Zhang, S. Meuter, A. N. Policheni, S. Kitsoulis, C.-N. Lee, M. O'Keeffe, L. C. Sullivan, A. G. Brooks, et al. 2012 DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc. Natl. Acad. Sci. USA 109: 16270-16275.
21. Limmon, G. V., M. Arredouani, K. L. McCann, R. A. Corn Minor, L. Kobzik, and F. Imani. 2008. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J. 22: 159-167.
22. Liao, J.-Y., S. A. Thakur, Z. B. Zalinger, K. E. Gerrish, and F. Imani. 2011. Inosine-containing RNA is a novel innate immune recognition element and reduces RSV infection. PLoS One 6: e26463.
23. Sirois, C. M., T. Jin, A. L. Miller, D. Bertheloot, H. Nakamura, G. L. Horvath, A. Mian, J. Jiang, J. Schrum, L. Bossaller, et al. 2013. RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA. [Published erratum appears in 2014 J. Exp. Med. 211: 1001.] J. Exp. Med. 210: 2447-2463.
24. Schmidt, A. M., S. D. Yan, S. F. Yan, and D. M. Stern. 2000. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498: 99-111.
25. Kierdorf, K., and G. Fritz. 2013. RAGE regulation and signaling in inflammation and beyond. J. Leukoc. Biol. 94: 55-68.
26. Neeper, M., A. M. Schmidt, J. Brett, S. D. Yan, F. Wang, Y. C. Pan, K. Elliston, D. Stern, and A. Shaw. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
27. Leclerc, E., G. Fritz, S. W. Vetter, and C. W. Heizmann. 2009. Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 1793: 993-1007.
28. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
29. Hori, O., J. Brett, T. Slattery, R. Cao, J. Zhang, J. X. Chen, M. Nagashima, E. R. Lundh, S. Vijay, D. Nitecki, et al. 1995. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761.
30. Sims, G. P., D. C. Rowe, S. T. Rietdijk, R. Herbst, and A. J. Coyle. 2010. HMGB1 and RAGE in inflammation and cancer. Annu. Rev. Immunol. 28: 367-388.
31. Ramasamy, R., S. F. Yan, and A. M. Schmidt. 2009. RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J. Leukoc. Biol. 86: 505-512.
32. Lan, T., E. R. Kandimalla, D. Yu, L. Bhagat, Y. Li, D. Wang, F. Zhu, J. X. Tang, M. R. Putta, Y. Cong, et al. 2007. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8. Proc. Natl. Acad. Sci. USA 104: 13750-13755.
33. Lan, T., M. Dai, D. Wang, F.-G. Zhu, E. R. Kandimalla, and S. Agrawal. 2009. Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies. J. Med. Chem. 52: 6871-6879.
34. Kandimalla, E. R., M. Struthers, A. J. Bett, T. Wisniewski, S. A. Dubey, W. Jiang, M. Precopio, Z. Sun, H. Wang, T. Lan, et al. 2011. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists. Cell. Immunol. 270: 126-134.
35. Carpenter, A. E., T. R. Jones, M. R. Lamprecht, C. Clarke, I. H. Kang, O. Friman, D. A. Guertin, J. H. Chang, R. A. Lindquist, J. Moffat, et al. 2006. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7: R100.
36. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60: 2126-2132.
37. Tian, J., A. M. Avalos, S.-Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, C. Sirois, et al. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8: 487-496.
38. Li, J., and A. M. Schmidt. 1997. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 272: 16498-16506.
39. Li, J., X. Qu, and A. M. Schmidt. 1998. Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J. Biol. Chem. 273: 30870-30878.
40. Tanaka, N., H. Yonekura, S. Yamagishi, H. Fujimori, Y. Yamamoto, and H. Yamamoto. 2000. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275: 25781-25790.
41. Youn, J. H., Y. J. Oh, E. S. Kim, J. E. Choi, and J.-S. Shin. 2008. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J. Immunol. 180: 5067-5074.
42. Campana, L., L. Bosurgi, M. E. Bianchi, A. A. Manfredi, and P. Rovere-Querini. 2009. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J. Leukoc. Biol. 86: 609-615.
43. Sha, Y., J. Zmijewski, Z. Xu, and E. Abraham. 2008. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180: 2531-2537.
44. Bell Jr., A. J., S. Chauhan, S. A. Woodson, and N. R. Kallenbach. 2008. Interactions of recombinant HMGB proteins with branched RNA substrates. Biochem. Biophys. Res. Commun. 377: 262-267.
45. Yanai, H., T. Ban, Z. Wang, M. K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, et al. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
46. Fischer, S., T. Grantzow, J. I. Pagel, M. Tschernatsch, M. Sperandio, K. T. Preissner, and E. Deindl. 2012. Extracellular RNA promotes leukocyte recruitment in the vascular system by mobilising proinflammatory cytokines. Thromb. Haemost. 108: 730-741.
47. Cabrera-Fuentes, H. A., M. L. Lopez, S. McCurdy, S. Fischer, S. Meiler, Y. Baumer, S. P. Galuska, K. T. Preissner, and W. A. Boisvert. 2015. Regulation of monocyte/macrophage polarisation by extracellular RNA. Thromb. Haemost. 113: 473-481.
48. Beltrami, C., T. G. Angelini, and C. Emanueli. 2015. Noncoding RNAs in diabetes vascular complications. J. Mol. Cell. Cardiol. 89(Pt. A): 42-50.
49. Lehmann, S. M., C. Krüger, B. Park, K. Derkow, K. Rosenberger, J. Baumgart, T. Trimbuch, G. Eom, M. Hinz, D. Kaul, et al. 2012. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat. Neurosci. 15: 827-835.
50. Alexandrov, P. N., P. Dua, J. M. Hill, S. Bhattacharjee, Y. Zhao, and W. J. Lukiw. 2012. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int. J. Biochem. Mol. Biol. 3: 365-373.
51. Jung, H. J., and Y. Suh. 2014. Circulating miRNAs in ageing and ageing-related diseases. J. Genet. Genomics 41: 465-472.
52. He, W. A., F. Calore, P. Londhe, A. Canella, D. C. Guttridge, and C. M. Croce. 2014. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc. Natl. Acad. Sci. USA 111: 4525-4529.
53. Jöckel, S., G. Nees, R. Sommer, Y. Zhao, D. Cherkasov, H. Hori, G. Ehm, M. Schnare, M. Nain, A. Kaufmann, and S. Bauer. 2012. The 29-O-methylation status of a single guanosine controls transfer RNA-mediated Toll-like receptor 7 activation or inhibition. J. Exp. Med. 209: 235-241.
54. Bauer, S., S. Pigisch, D. Hangel, A. Kaufmann, and S. Hamm. 2008. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9. Immunobiology 213: 315-328.
55. Karikó, K., M. Buckstein, H. Ni, and D. Weissman. 2005. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23: 165-175.
56. Julian, M. W., G. Shao, Z. C. Vangundy, T. L. Papenfuss, and E. D. Crouser. 2013. Mitochondrial transcription factor A, an endogenous danger signal, promotes TNFa release via RAGE-and TLR9-responsive plasmacytoid dendritic cells. PLoS One 8: e72354.
57. Hudson, B. I., A. Z. Kalea, M. Del Mar Arriero, E. Harja, E. Boulanger, V. D'Agati, and A. M. Schmidt. 2008. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J. Biol. Chem. 283: 34457-34468.
58. Sakaguchi, M., H. Murata, K. Yamamoto, T. Ono, Y. Sakaguchi, A. Motoyama, T. Hibino, K. Kataoka, and N.-H. Huh. 2011. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 6: e23132.